Skip to main content
Premium Trial:

Request an Annual Quote

Which Do You Prefer -- Titrations or PowerPoint Presentations?

John Lechleiter has been named the new CEO of Eli Lilly, reports the Wall Street Journal, and Derek Lowe thinks that's unusual (but still cool) because Lechleiter's a researcher who worked his way up from the bench to management. Lowe ponders why that doesn't happen more often in pharma. One reason is that a lot of scientists don't want to be managers. Another is that "scientists, taken as a class, do not always turn into the best managers," Lowe says. "Putting it delicately, there are a number of personality types reasonably well-suited for science, but not so well-suited for supervising and developing other people."

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.